Related Experiment Video

Updated: Mar 24, 2026

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
06:53

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry

Published on: November 23, 2011

37.9K

Mitochondrial disorders in children: toward development of small-molecule treatment strategies

Werner Jh Koopman1, Julien Beyrath2, Cheuk-Wing Fung3

  • 1Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands Centre for Systems Biology and Bioenergetics, Radboud University Medical Center, Nijmegen, The Netherlands.

EMBO Molecular Medicine
|March 9, 2016
PubMed

Insights

This review explores mitochondrial disease in children, focusing on nuclear DNA mutations affecting oxidative phosphorylation. It details diagnostic approaches and novel small-molecule treatments for these complex genetic disorders.

Area of Science:

  • Pediatric genetics
  • Mitochondrial biology
  • Biochemistry

Background:

  • Mitochondrial diseases are a group of debilitating genetic disorders.
  • Oxidative phosphorylation (OXPHOS) dysfunction is a common cause, often linked to nuclear DNA mutations.
  • Pediatric mitochondrial disorders present significant diagnostic and therapeutic challenges.

Purpose of the Study:

  • To review the pathophysiology of pediatric mitochondrial diseases caused by nuclear DNA mutations.
  • To discuss current diagnostic strategies, including whole-exome sequencing and complementation studies.
  • To explore potential small-molecule treatment strategies and clinical trial designs.

Main Methods:

  • Review of current literature on mitochondrial disease pathophysiology and treatment.
  • Analysis of diagnostic techniques for mitochondrial disorders in children.
  • Examination of cellular studies and small-molecule drug development.

Main Results:

  • Nuclear DNA mutations in OXPHOS assembly factors are a key focus, particularly complex I deficiency.
  • Whole-exome sequencing and cellular complementation are crucial diagnostic tools.
  • Small-molecule therapies show promise for treating mitochondrial diseases.

Conclusions:

  • Understanding OXPHOS dysfunction is vital for diagnosing and treating pediatric mitochondrial diseases.
  • Targeted small-molecule therapies offer a potential treatment avenue.
  • Further clinical trials are needed to validate new therapeutic strategies.

Keywords:
childrenclinical trialdrug developmentmitochondriaoutcome measures

More Related Videos

Generation of Human Brain Organoids for Mitochondrial Disease Modeling08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.9K
Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes08:56

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

845

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
327
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.6K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.3K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.7K